Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash Flows from Operating Activities    
Net loss $ (1,827) $ (10,133)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 2,351 3,456
Depreciation and amortization 1,195 1,287
Changes in fair value of derivative liabilities (229) (189)
Non-cash interest expense 160 270
Inventory write-down 0 (577)
Other non-cash expenses 20 8
Changes in operating assets and liabilities:    
Inventory (3,762) 1,989
Prepaids and other assets 2,355 955
Accounts payable (68) (436)
Accrued expenses (232) (2,720)
Deferred revenue 1,545 (1,207)
Operating lease right-of-use assets and liabilities (696) 579
Other liabilities 26 (207)
Net cash provided by (used in) operating activities 838 (6,925)
Cash Flows from Investing Activities    
Cash paid for acquisitions 0 (2,848)
Proceeds from sale of property and equipment 0 13
Purchase of property and equipment (714) (1,133)
Net cash used in investing activities (714) (3,968)
Cash Flows from Financing Activities    
Payment of issuance costs related to preferred stock and SEPA 0 (18)
Payment on finance agreement (471) (118)
Payments related to stock-based award activities, net (507) (1,063)
Proceeds from issuance under employee stock purchase plan 117 141
Payment of debt modification costs 0 (44)
Net cash used in financing activities (861) (1,102)
Net decrease in cash, cash equivalents and restricted cash (737) (11,995)
Cash, cash equivalents and restricted cash at beginning of period 11,792 24,304
Cash, cash equivalents and restricted cash at end of period 11,055 12,309
Supplemental Disclosure    
Cash paid for taxes 29 32
Cash paid for interest 669 436
Supplemental Disclosure of Non-Cash Investing and Financing Activities    
Purchase of property and equipment in accounts payable and accrued liabilities 116 0
Debt issuance costs in accounts payable and accrued liabilities 0 13
Costs of debt extinguishment in accrued liabilities 0 77
Financing agreement entered into for prepaid insurance 683 588
Preferred Stock issuance costs, common stock issuance costs and costs to settle Additional Shares Liability in accounts payable and accrued liabilities 0 25
Reconciliation of cash, cash equivalents, and restricted cash:    
Cash and cash equivalents 7,988 8,907
Restricted cash, current 2,165 2,400
Restricted cash, noncurrent 902 1,002
Total cash, cash equivalents and restricted cash $ 11,055 $ 12,309